The acidic dipeptide N-acetylaspartylglutamate (NAAG), which satisfies many of the criteria for a neurotransmitter, was identified immunohistochemically within two human retinae. We observed NAAG immunoreactivity in retinal ganglion cells, their dendrites in the inner plexiform layer, and their axons in the optic nerve fiber layer. The vast majority of ganglion cells were stained, including displaced ganglion cells, ganglion cells of different sizes, and those whose dendrites arborized in the inner and outer sublaminae of the inner plexiform layer, that is, presumed On-and Off-cells. The sizes of labeled and unlabeled cells in the ganglion cell layer, as measured in counterstained material, suggest that the unlabeled cells consist primarily or only of displaced amacrine cells. We also saw immunoreactivity in small cells along the inner margin of the inner nuclear layer, presumably amacrine cells, and in small cells with little cytoplasm in the inner plexiform and ganglion cell layers, presumably displaced amacrine cells. These results are consistent with a role for NAAG in the transmission of visual information from the retina to the rest of the brain. Further, they are similar to those reported previously in rat, cat and monkey, thus demonstrating the relevance of previous studies to humans.
INTRODUCTION
The neurotransmitters used by mammalian retinal ganglion cells remain unknown, although receptors for the acidic amino acids, aspartate and glutamate, appear to be involved in retinogeniculate (Kemp & Sillito, 1982; Crunelli, Kelly, Leresche & Pirchio, 1987; Sillito, Murphy & Salt, 1990; Sillito, Murphy, Salt & Moody, 1990) , retinocollicular (Roberts, Eaton & Salt, 1991) and retinohypothalamic (Cahill & Menaker, 1989; Takeuchi, Takashima, Katoh, Nishikawa & Takahashi, 1991) transmission. However, although glutamate immunoreactivity has been localized in retinal ganglion cells and their terminals (Montero & Wenthold, 1989; Montero, 1990 Montero, , 1994 Davanger, Ottersen & Storm-Mathisen, 1991; Nunes Cardozo, Buijs & Van der Want, 1991; Crooks & Kolb, 1992) , neither glutamate nor aspartate is released from those terminals in a calcium-dependent fashion (Sandberg & Corazzi, 1983; Tsai, Forloni, Robinson, Stauch & Coyle, 1988; Tsai, Stauch, Vornov, Deshpande & Coyle, 1990 (Curatolo, D'Arcangelo & Lino, 1965; Miyamoto, Kakimoto & Sano, 1966; Koller, Zaczek & Coyle, 1984) that activates an acidic amino acid receptor. Most studies suggest that NAAG acts preferentially at the N-methyl-D-aspartate (NMDA) receptor (Westbrook, Mayer, Namboodiri & Neale, 1986; Sekiguchi, Okamoto & Sakai, 1987; Trombley & Westbrook, 1990; Sekiguchi, Wada & Wenthold, 1992; Koenig, Rothbard, DeCoster & Meyerhoff, 1994; Valivullah, Lancaster, Sweetnam & Neale, 1994) , but there are several reports of activity at other types of glutamate receptor (JoWls, Van Veldhuizen, Urban & DeKloet, 1987; GaUi, Godeheu, Artaud, Desce, Pittaluga, Barbeito, Glowinski & Chframy, 1991; Wroblewska, Wroblewski, Saab & Neale, 1993) . Although its role in nervous system function has yet to be determined, several lines of evidence suggest that NAAG may be a neurotransmitter (reviewed by Blakely & Coyle, 1988) . Most importantly, NAAG has been localized immunocytochemically within synaptic vesicles (Williamson & Neale, 1988b) , and it is released in a calcium-dependent manner by depolarization (Pittaluga, Barbeito, Serval, Godeheu, Artaud, Glowinski & Chframy, 1988; Tsai et al., 1988 Tsai et al., , 1990 Williamson & Neale, 1988a; Zollinger, Amsler, Do, Streit & Cufnod, 1988 ; 941 942 S.B. TIEMAN and D. G. TIEMAN Williamson, Eagles, Brady, Moffett, Namboodiri & Neale, 1991) .
Physiological support for NAAG's role as an excitatory neurotransmitter is mixed. Despite the many positive reports cited above, NAAG was reported to be ineffective in activating cells in the piriform cortex (Whittemore & Koerner, 1989) or ventrobasal nucleus (Henderson & Salt, 1988) of the rat or the lateral geniculate nucleus (LGN) of the cat (Jones & Sillito, 1992) . However, we have found that NAAG can excite cells in slices of rat LGN (Tieman, Hori, Carpenter & Tieman, 1991) , consistent with excitatory effects in another retinal target, the suprachiasmatic nucleus (Bos & Mirmiran, 1993) . Such physiological studies are not possible in human, but we can examine the distribution of NAAG in human tissue and compare it to that in other species. These comparisons can be used in part to evaluate the relevance to human of physiological studies performed in other species. We have previously identified NAAG-like immunoreactivity in retinal ganglion cells and amacrine cells of cat (Tieman, Cangro & Neale, 1987) and monkey (Tieman, Neale & Tieman, 1991) . We now report a similar distribution in human retina. Brief reports of some of these results have appeared elsewhere Tieman, Butler & Neale, 1988) .
METHODS

Antisera
The antisera were prepared as previously described (Anderson, Monaghan, Cangro, Namboodiri, Neale & Cotman, 1986; Anderson, Borja, Cotman, Moffett, Namboodiri & Neale, 1987; Cangro, Namboodiri, Sklar, Corigliano-Murphy & Neale, 1987) . Briefly, NAAG was synthesized, purified and coupled to thyroglobulin with carbodiimide, and the conjugate used to immunize two rabbits. The antisera have been tested by ELISA and immunoblotting and have shown minimal cross-reactivity with NAAG-related molecules including glutamate, aspartate, ~-glutamylglutamate, aspartylglutamate and Nacetylaspartate (Anderson et al., 1986; Cangro et al., 1987; Kowalski, Cassidy, Namboodiri & Neale, 1987) . Affinity-purified antiserum was prepared as described previously (Moffett, Cassidy & Namboodiri, 1989) . The affinity-purified antiserum shows even less cross-reactivity with NAAG-related molecules (Tieman, Moffett & Irtenkauf, 1991a, b) .
Subjects and histology
We studied the pattern of NAAG immunoreactivity in the retinae of two caucasian males, aged 70 yr (H-l) and 51 yr (H-2). The eyes, which were obtained from the Lions Eye Bank at the Albany Medical College, were placed in cold (4°C) fixative 24 hr (H-l) or 8.5 hr (H-2) after death, where they remained for 2 days (H-l) or 4 days (H-2). The fronts of the eyes were removed to improve retinal access to the fixative, which was a mixture of 4% paraforrnaldehyde and 4% 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (carbodiimide, Sigma E7750) in 0.1 M phosphate buffer (pH 7.4). Fixation with aldehydes alone does not efficiently retain NAAG (Anderson et al., 1986) because of the peptide's small size and acetylated amine group. Carbodiimide is effective because it promotes the formation of peptide bonds between NAAG's free carboxyl groups and free amine groups in the tissue.
The eyes were then rinsed overnight in phosphate buffer and cryoprotected in buffered sucrose. Pieces of retina were then frozen, sectioned at 30/~m into phosphate buffer and stored at 4°C. Some pieces of retina were sectioned with a cryostat, mounted directly onto gelatinized slides, and stored at -20~C.
lmmunocytochemistry
Sections were stained on the slide or free-floating as described previously (Tieman et al., 1987 (Tieman et al., , 1991b . Briefly, sections were incubated overnight at 4°C in NAAG antiserum (bleed 9 from rabbit IX or bleed 8 or 10 from rabbit X) diluted 1:4000 to 1:16,000 or affinitypurified NAAG antiserum diluted 1 : 1500 to 1 : 2500, incubated in biotinylated goat anti-rabbit (Vector) at 1:200 or 1:800, exposed to avidin-biotin-peroxidase complex (Vector), and reacted in diaminobenzidine and H~O2. To minimize handling, free-floating sections were transferred from solution to solution in tissue carriers constructed of small hollow plastic cylinders with silk screen glued to the bottom. In some cases, the staining was enhanced with cobalt chloride (Adams, 1981) . Selected sections were counterstained with thionin.
Controls
The specificity of the stt, ining was demonstrated by the following: first, the pattern of staining was similar with antisera from two different rabbits and with the affinitypurified antiserum. Second, we substituted normal rabbit serum for the anti-NAAG sera, and obtained no staining or only very faint staining. Third, we were able to block staining by pre-incubating the anti-NAAG sera with NAAG conjugated to bovine serum albumen (NAAG-BSA) at 1.5/zg/ml. Concentrations as low as 150 ng/ml diminished, but did not block the staining. In contrast, we were unable to block staining with BSA conjugated to either N-acetylaspartate or aspartylglutamate at concentrations of 500/tg/ml, the highest concentrations tested. These results are consistent with earlier blocking data using these antisera (Anderson et al., 1986 (Anderson et al., , 1987 Cangro et al., 1987; Tieman et aL, 1987 Tieman et aL, , 1991b , and further demonstrate their specificity. We did not test blocking with glutamate or aspartate conjugated to BSA because previous studies found no cross-reactivity with either Kowalski et al., 1987; Tieman et al., 1991a) .
Cell measurements
To determine the relative sizes of labeled and unlabeled cells in the retinal ganglion cell layer, we measured the areas of both types of cells in a portion of one section of counterstained retina from H-2. Cells were drawn at 1250 x and entered directly into a computer with the aid of a mouse-controlled cursor and a drawing tube positioned so that the image displayed on a computer monitor was superimposed on the image of the cell. For each cell the experimenter indicated whether the cell was labeled or unlabeled (i.e. stained only by thionin). The computer then calculated the area of each cell and tabulated the results.
RESULTS
The results for the two retinae were essentially similar, although most of the illustrations were taken from that of H-2, for which the preservation was superior. The heaviest staining was in the retinal ganglion cells and their processes; amacrine cells were more lightly stained.
The perikarya of the retinal ganglion cells were stained, as were their dendrites in the inner plexiform layer and their axons in the optic nerve fiber layer. In regions where the optic nerve fiber layer was thick, the fixation of the other layers was relatively poor, as if the fixative had failed to penetrate well. For this reason, all of the illustrations were taken from sections of retina where the optic nerve fiber layer was relatively thin. Figure I (A) shows a tangential section of peripheral retina. Scattered ganglion cells of different sizes were labeled (large arrows), as were retinal ganglion cell axons (small arrows). These were somewhat irregular and broken up, as if they were starting to degenerate. There was also some staining throughout the neuropil of the inner plexiform layer (IPL). Figure I(B) shows that all or nearly all of the retinal ganglion cells in parafoveal retina were labeled, including cells throughout the depth of the ganglion cell layer, suggesting, by analogy with the monkey, that all major classes of ganglion cells contain NAAG (i.e., M, P, midbrain projecting, On-and Off-), since these various types occur at different depths of the ganglion cell layer (Perry & Silveira, 1988) .
The dendrites of some of the retinal ganglion cells could be followed for some distance into the inner plexiform layer. Cells with dendrites arborizing in the inner sublamina of the inner plexiform layer were labeled [ Fig. I(D, E) ], as were those with dendrites arborizing in the outer sublamina [ Fig. I(C, D) ]; that is, both On-center and Off-center cells (Nelson, Famiglietti & Kolb, 1978) were labeled. Labeled ganglion cells included both large and small cells [ Fig. I(A, D-F) ], that is, both M and P cells [terminology of Shapley and Perry (1986) ]. We also saw numerous large, stained cells in the inner nuclear layer with relatively large amounts of cytoplasm [indicated by solid triangles in Fig. I(B, E, F) ]. Based on their size and morphology, we believe that these are displaced ganglion cells. The cell indicated in I(B) is much smaller than those in I(E, F), but I(B) is from the parafovea, whereas I(E, F) are from the periphery (eccentricity about 15 mm), and ganglion cells are much smaller in central than peripheral retina. At all eccentricities, the cells we are calling displaced ganglion cells fall within the size range of the ganglion cells in the ganglion cell layer. In summary, the size, distribution and dendritic branching of labeled cells in the ganglion cell and inner nuclear layers suggest that all major classes of ganglion cells in the human retina contain NAAG.
In counterstained sections, those cells in the retinal ganglion cell layer that were not immunoreactive for NAAG were small and had relatively little cytoplasm, morphology characteristic of displaced amacrine cells (Curcio & Allen, 1990 ). Most of the stained cells were larger, had more cytoplasm, and often had eccentric nuclei, morphology typical of ganglion cells (Curcio & Allen, 1990 ). We measured the areas of 410 cells in the retinal ganglion cell layer from one counterstained section from H-2 at an eccentricity of 15-21 mm. Of these, slightly more than half (218) were labeled. However, we may have underestimated the number of unlabeled cells, because it was difficult to see through the immunolabeled processes of other cells, those cells that were only lightly stained by the thionin. The distribution of cell sizes is shown in Fig. 2 . The unlabeled cells (open bars) were smaller, on average, than the labeled cells (solid bars), although the range of sizes for the unlabeled cells was within that for the labeled cells. This suggests that the population of unlabeled cells consists of displaced amacrine cells, although it may include a few small ganglion cells.
Many other stained cells were located in the inner nuclear layer along the inner margin [indicated by open triangles in Fig. I (A, C-F)]; these are presumably amacrine cells. In general, these were not as darkly stained as the ganglion cells. They were smaller, with only thin rims of cytoplasm. The difference between these and the ones we are calling displaced ganglion cells can be seen in Figure I(E, F) . The frequency of labeled amacrine cells was greater in peripheral than in central retina. Some stained cells in the inner plexiform and ganglion cell layers had morphologies suggesting that they are displaced amacrine cells (Curcio & Allen, 1990) . That is, they were among the smallest cells in the ganglion cell layer at that eccentricity, had only thin rims of cytoplasm, and were often within or near the inner plexiform layer [open arrow, Fig. I(A, C) ].
DISCUSSION
We observed NAAG-like immunoreactivity in retinal ganglion cells and amacrine cells. NAAG-like immunoreactivity has previously been identified in both ganglion cells and amacrine cells of turtle (Eldred, Coyle & Joneckis, 1992) , chick , cat (Tieman et al., 1987) and monkey (Tieman et al., 1991b) and in amacrine cells of frog (Kowalski et al., 1987) . NAAG-immunoreactive amacrine cells in cat and monkey include displaced amacrine cells (Tieman & Fry, 1989; Tieman et al., 1991b) , as they did here. NAAG immunoreactive amacrine cells are least frequent in cat and most frequent in frog and chick. In those species for which immunoreactivity is present in both amacrine cells and ganglion cells, the staining in the amacrine cells tends to be less intense (Tieman et al., 1987 (Tieman et al., , 1991b Williamson et al., 1991) , as it was here. Nevertheless, The section from which these data were taken was from H-2, stained with antiserum X-10 at 1:4000, cobalt-intensified and counterstained with thionin.
NAAG is released from these cells in a calciumdependent manner . NAAG-like immunoreactivity was observed in the vast majority of retinal ganglion cells, including both large and small cells, putative On-cells, Off-cells and displaced ganglion cells. Further, our analysis of cell sizes in a counterstained section is consistent with the idea that all ganglion cells contain NAAG. First, the proportion of labeled cells is what would be expected if all ganglion cells and a few displaced amacrine cells contain NAAG, since 50% or more of the neurons in the retinal ganglion cell layer are displaced amacrine cells, ranging from <3% in central retina to 70% at the extreme periphery (Curcio & Allen, 1990) . Second, the distribution of cell sizes is consistent with this suggestion, since the sizes of unlabeled cells fell at the small end of that for the labeled cells. Finally, the morphology of the unlabeled cells resembled that of displaced amacrine cells (Curcio & Allen, 1990) . The localization of NAAG in most or all retinal ganglion cells, including representatives of all of the major classes, is similar to what we found in the cat (Tieman et al., 1987) and monkey (Tieman et al., 1991b) . The similarity of the results reported here to those in other mammals (Anderson et al., 1987; Tieman et al., 1987 Tieman et al., , 1991b suggests that results from functional studies of NAAG in other species can reasonably be extrapolated to human.
NAAG immunoreactivity has been observed in the neuropil of the retinal target areas in rat (Anderson et aL, 1987; Moffett et al., 1991) , cat (Tieman et al., 1987 (Tieman et al., , 1991a and monkey (Tieman et al., 1991a) . The blocking data for the retinal ganglion cells in this and previous experiments suggest that the antibodies are in fact recognizing NAAG. Further, the presence of NAAG in retinal target areas (LGN and superior colliculus) of the rat and monkey has been confirmed using high performance liquid chromatography (HPLC) (Anderson et al., 1987; Moffett et al., 1991; Molinar-Rode & Pasik, 1992) . Unilateral eye removal in rat decreases NAAG levels in contralateral LGN and superior colliculus, as assayed both with HPLC and with immunohistochemistry (Anderson et al., 1987; Moffett et al., 1991) . Similarly, removal of one eye in the cat leads to decreased NAAG immunoreactivity in ipsilateral geniculate layer A1 and contralateral superior colliculus and geniculate layer A (Tieman et al., 1991a) and lesions of the optic tract in monkey decrease NAAG levels in ipsilateral LGN, as determined by HPLC (Molinar-Rode & Pasik, 1992) . Further, the decreases in NAAG produced by optic deafferentation are greater than those observed for aspartate or glutamate (Williamson, Moffett, Garrison, Murphy, Palkovits, Neale & Namboodiri, 1989; Molinar-Rode & Pasik, 1992) . Finally, NAAG is released in a calcium-dependent manner in chick optic tectum and rat superior colliculus (Tsai et al., 1990) upon stimulation of the optic nerve fibers. These results suggest that NAAG may participate in chemical neurotransmission from retinal ganglion cells.
As noted in the Introduction, most or all mammalian [including human (Davanger et al., 1991; Crooks & Kolb, 1992) ] retinal ganglion cells and their terminals also contain glutamate. Since both NAAG and glutamate are present, their respective roles are not clear. Glutamate could be a synthetic precursor or a breakdown product of NAAG. Similarly, NAAG could provide a discrete neuronal source for a neurotransmitter pool of glutamate. Several lines of evidence favor NAAG over aspartate or glutamate as the transmitter for retinal ganglion cells, discussed in Tieman et al. (1991b) [but see Montero (1994) ]. Of the evidence favoring NAAG, the most critical is that showing calcium-dependent release of NAAG, but not aspartate or glutamate, from retinal terminals (Tsai et al., 1988 (Tsai et al., , 1990 Williamson et al., 1991) . On the other hand, NAAG's ability to excite neurons in retinal targets is controversial (Tieman et al., 1991; Jones & Sillito, 1992; Bos & Mirmiran, 1993) . It is possible that NAAG is released, but is immediately hydrolyzed to N-acetylaspartate and glutamate, and that glutamate is the substance that excites the postsynaptic cell. However, several recent studies have suggested that NAAG can act directly, and not just by means of the hydrolyzed glutamate (Galli et al., 1991; Koenig et al., 1994; Valivullah et al., 1994) . Additional studies involving physiology and pharmacology will be needed to unravel the relative contributions of glutamate and NAAG to retinofugal transmission.
